**Total Return Swap Contract**

This contract is a Total Return Swap (TRS) between two parties, Party1 and Party2, dated October 10, 2004. The contract is for a period of two years, with the termination date being October 12, 2006.

**General Terms**

* Trade Date: October 10, 2004
* Termination Date: October 12, 2006
* Mandatory Early Termination: Not applicable
* Notional Amount: USD 37,440,000 (for the interest leg) and USD 760,400 (for the equity leg)
* Business Day Convention: None
* Day Count Fraction: ACT/360

**Interest Leg**

* Payer: Party2
* Receiver: Party1
* Interest Rate: USD SOFR-COMPOUND
* Calculation Period: Annually, from October 12 to October 12 of the consecutive year
* Payment Dates: Annually, 2 business days after October 12 of each year, commencing on October 14, 2004, and ending on October 14, 2006
* Day Count: ACT/360

**Equity Leg**

* Payer: Party1
* Receiver: Party2
* Underlier: Shire Pharmaceuticals Group - American Depositary Receipts (SHPGY.O)
* Return Terms: Total Return
* Dividend Return Terms: Ex-Dividend, Record Amount, 85% dividend payout ratio
* Dividend Currency: Determined by Dividend Currency
* Dividend Period: From October 10, 2004, to October 12, 2006
* Payment Dates: Annually, 2 business days after October 14 of each year, commencing on October 14, 2004, and ending on October 14, 2006

**Collateral**

* Independent Amount: USD 1,000
* Payer Party Reference: Party2
* Receiver Party Reference: Party1
* Payment Detail: Payment Date: October 1, 2005; Payment Amount: USD 1,000

**Counterparty**

* Party1: ABCD Securities Inc.
* Party2: HedgeCo Capital L.L.C.

**Representations**

* Each party represents that it is acting for its own account and has made its own independent decisions to enter into this contract.
* Each party represents that it is capable of assessing the merits and risks of this contract and understands and accepts the terms, conditions, and risks of this contract.

**Risk Disclosure**

* There are significant risks associated with this contract, including foreign exchange risk, price risk, liquidity risk, and credit risk.
* Counterparties should consult their own financial, legal, accounting, and tax advisors about the risks associated with this contract.

**Scenario Analysis**

* The following scenario analysis is provided for illustrative purposes only and should not be relied upon by Party2.
* Scenario 1: USD SOFR-COMPOUND remains unchanged over the tenor of the trade.
* Scenario 2: USD SOFR-COMPOUND increases over the tenor of the trade.
* Scenario 3: USD SOFR-COMPOUND decreases over the tenor of the trade.

**Mark to Market (MTM) Sensitivity Analysis**

* The following MTM analysis is provided for illustrative purposes only and should not be relied upon by Party2.
* MTM Sensitivity due to parallel shift in USD SOFR-COMPOUND Curve immediately after Trade Date.
* MTM Sensitivity due to parallel shift in USD SOFR-COMPOUND Curve as on Mandatory Termination Date compared to Trade Date.

**Level of Pricing Variables and Impact of Variables on Pricing**

* The following analysis is provided for information and illustrative purposes only and should not be relied upon by Party2.
* The market level of primary market variables used in determining the price of the transaction is as follows: USD 10-year SOFR-COMPOUND Rate: 4.427%.

**Valuation Statements**

* Valuation statements in relation to all transactions executed between the parties will be made available to Party2 on the "Optimize" application present on JPMorgan's online platform, J.P.Morgan Markets ("Optimize Platform").

**Representations and Warranties**

* Each party represents and warrants that it has the power to enter into this contract and to deliver any document relating to this contract and to perform its obligations under this contract.

**Acceptance and Agreement**

* This contract is accepted and agreed to by Party1 and Party2 on the date hereof.